This article examines Semax effects on striatal dopaminergic signaling in rodent models, covering DAT expression, D1/D2 receptor modulation, DOPAC/DA ratio changes, and the relationship with established BDNF/TrkB neurotrophic pathways.

A preclinical research overview of Noopept mechanisms related to glutamate toxicity reduction, calcium signaling in neuronal models, and tau phosphorylation in Abeta25-35 challenge studies.

A preclinical research review of Dihexa (PNB-0408) as an HGF potentiator, examining c-Met receptor phosphorylation, dendritic spine formation, and synaptogenesis in hippocampal neuron models alongside key translational limitations.

Analysing Selank’s impact on IFN-gamma and IL-6 expression in splenic leukocyte cultures under acute stress models.

Preclinical analysis of Semax heptapeptide neurotrophic pathways, transcriptional BDNF/NGF upregulation, and melanocortin receptor interactions.

A research-context review of Noopept preclinical findings on NGF and BDNF mRNA upregulation in rodent hippocampal tissue and the proposed neuroprotective mechanisms in beta-amyloid toxicity models.

This article investigates Selank’s modulation of the GABAergic system and GABA-A receptor conductance dynamics in preclinical models.

An analysis of Semax’s reported effects on BDNF and NGF expression, TrkB receptor phosphorylation, monoaminergic system modulation, and melanocortin receptor interactions in preclinical brain injury and ischemia research models.

An analysis of Selank’s cytokine-regulating properties in rodent stress models, covering IL-1beta, IL-6, and TGF-beta1 modulation in a social stress paradigm.

A preclinical research overview of Noopept examining AMPA receptor potentiation, BDNF and NGF neurotrophic signaling, and synaptic plasticity mechanisms in rodent cognition and neuroprotection models.